TCF4 and glioblastoma: Based on this knowledge and a recent study describing that TSA and SAHA were able to reduce TCF4 levels by acting on its transcription and protein degradation in colorectal cancer cells [15], we hypothesized that a HDI-induced suppression of TCF4 levels cells could ignite neuronal differentiation in GBM and sensitize them to chemotherapeutics.